| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/23/2007 | US7166301 Immediate release medicinal compositions for oral use |
| 01/23/2007 | US7166300 Agent for inducing hair growth containing extracts of saw palmetto and swertia |
| 01/23/2007 | US7166299 Comprises ursodeoxycholic acid for treating gastritis and peptic ulcer disease |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166296 Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 |
| 01/23/2007 | US7166295 Methods of treatment and diagnostic visualization, particularly in cancer |
| 01/23/2007 | US7166292 Top-biased beneficial components on substrates |
| 01/23/2007 | US7166281 Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings |
| 01/23/2007 | US7165510 Bovine germicide application device |
| 01/23/2007 | CA2407325C Low ionic strength ophthalmic compositions |
| 01/23/2007 | CA2348086C Controlled-release pharmaceutical formulations |
| 01/23/2007 | CA2345466C Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 01/23/2007 | CA2331288C Aqueous process for manufacturing paroxetine solid dispersions |
| 01/23/2007 | CA2277956C Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| 01/23/2007 | CA2216169C Use of compositions comprising stabilized biologically effective compounds |
| 01/23/2007 | CA2211400C Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
| 01/23/2007 | CA2208495C The preparation of salts of pharmaceutical active substances which have acidic groups |
| 01/23/2007 | CA2107400C Method of grinding pharmaceutical substances |
| 01/18/2007 | WO2007009023A2 Chemically cross-linked elastomeric microcapsules |
| 01/18/2007 | WO2007009014A2 Personal topical disinfectant device |
| 01/18/2007 | WO2007008894A2 Cyclosporin compositions |
| 01/18/2007 | WO2007008752A2 Sustained release pharmaceutical compositions for highly water soluble drugs |
| 01/18/2007 | WO2007008666A2 Compositions and methods for improving vision using adherent thin films |
| 01/18/2007 | WO2007008427A2 Aerosol compositions and methods |
| 01/18/2007 | WO2007008389A2 Use of color changing indicators in consumer products |
| 01/18/2007 | WO2007008350A1 Pharmaceutical formulations of endo-n-(9- methyl-9-azabicyclo[3 .3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride |
| 01/18/2007 | WO2007008305A1 Asymmetrically coated tablet |
| 01/18/2007 | WO2007008206A1 Dilution resistant viscoelastic compositions |
| 01/18/2007 | WO2007008156A1 A pharmaceutical composition comprising a substituted phenylpropionic acid as a free acid and as tert-butyl amine salt thereof |
| 01/18/2007 | WO2007007863A1 Percutaneously absorptive ophthalmic preparation comprising olopatadine |
| 01/18/2007 | WO2007007851A1 Percutaneously absorptive ophthalmic preparation comprising epinastine |
| 01/18/2007 | WO2007007659A1 Tablet |
| 01/18/2007 | WO2007007656A1 Pharmaceutical composition containing thiazolidinedione compound |
| 01/18/2007 | WO2007007059A1 Fentanyl formulation containing an essential oil |
| 01/18/2007 | WO2007007021A1 Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 01/18/2007 | WO2007006885A2 Method for producing a powder containing xylitol crystal particles with another polyol |
| 01/18/2007 | WO2007006628A1 Method for coating dimensionally stable particles with finely divided dimensionally stable particles |
| 01/18/2007 | WO2007006529A1 Transdermal therapeutic system comprising a fragrance |
| 01/18/2007 | WO2007006443A1 Extracts of ginkgo biloba |
| 01/18/2007 | WO2007006427A1 Coiled wire for the controlled release of dugs to the eye |
| 01/18/2007 | WO2007006353A2 Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values |
| 01/18/2007 | WO2007006334A1 Clear pharmaceutical aqueous microemulsion comprising propofuol and process for preparation |
| 01/18/2007 | WO2007006232A1 Hyaluronic acid phospholipid complex and preparing method thereof |
| 01/18/2007 | WO2007006208A1 Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 01/18/2007 | WO2007006203A1 A capsule formulation for treating hypertension and coronary heart disease and process for preparation thereof |
| 01/18/2007 | WO2007006197A1 Use of levo-ornidazole for preparing antiparasitic infection drug |
| 01/18/2007 | WO2006127121A3 Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use |
| 01/18/2007 | WO2006122022A3 Modified release famciclovir pharmaceutical compositions |
| 01/18/2007 | WO2006117666A3 Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery |
| 01/18/2007 | WO2006116349A3 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy |
| 01/18/2007 | WO2006087613A3 Stable oral benzimidazole compositions prepared by non-aqueous layering process |
| 01/18/2007 | WO2006078282A3 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 01/18/2007 | WO2006060759A3 A sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal |
| 01/18/2007 | WO2006056306A3 Hydrogel polymeric conjugates of a prodrug |
| 01/18/2007 | WO2006009801A3 Compositions and methods for treating central precocious puberty |
| 01/18/2007 | WO2005112564A3 Germline and sequence variants of humanized antibodies and methods of making and using them |
| 01/18/2007 | WO2005084307A3 Use of lipid conjugates in the treatment of disease |
| 01/18/2007 | WO2005079384A3 Expandable gastric retention device |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | US20070016171 Implantable perfusion device |
| 01/18/2007 | US20070016170 Infusion device with bolus alarm deactivation and method of using the same |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015844 Bioresorbable hydrogel compositions for implantable prostheses |
| 01/18/2007 | US20070015824 Side effects reduction; depression, fibromyalgia, anxiety, panic disorder, agoraphobia, post traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, autism, schizophrenia, obesity |
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015785 Crystalline Micronisate, Process for the Manufacture Thereof and Use Thereof for the Preparation of a Medicament |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015736 Filling plastic container with bisphosphonate solution; heat sterilization |
| 01/18/2007 | US20070014887 Medicated chewing gum delivery system for nicotine |
| 01/18/2007 | US20070014876 Synergistic compositions and method for potentiating anti-oxidative activity |
| 01/18/2007 | US20070014875 Novel drug delivery system for proton pump inhibitors and process thereof |
| 01/18/2007 | US20070014865 Chemically stable, dry-flow, low compact, dust free, soluble granules of phosphoroamidothioate prepared by a process of dry granulation by agitative balling |
| 01/18/2007 | US20070014864 Novel pharmaceutical granulate |
| 01/18/2007 | US20070014863 Method of controlling paticle size of retinoic acid nanoparticles coated with polyvalent metal inorganic salt and nanoparticles obtained by the controlling method |
| 01/18/2007 | US20070014862 Device for treating wound gaps |
| 01/18/2007 | US20070014861 Treatment of proctitis |
| 01/18/2007 | US20070014860 Treatment of esophagitis |
| 01/18/2007 | US20070014859 Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate |
| 01/18/2007 | US20070014858 Method for controlling lag time of in-situ passageway formation in osmotic delivery system |
| 01/18/2007 | US20070014857 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/18/2007 | US20070014856 Drugs for disintegration on polymer to make dispersion endothermic enthalpy of solution |
| 01/18/2007 | US20070014855 Stable desloratadine compositions |
| 01/18/2007 | US20070014854 Novel granulation process |
| 01/18/2007 | US20070014853 Pharmaceutical dosage form containing novel pharmaceutical granulate |
| 01/18/2007 | US20070014852 for assisting in the identification of a region on the tablet that is desired to be able to be broken; breaking allows production of smaller dosage forms |
| 01/18/2007 | US20070014851 Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts |
| 01/18/2007 | US20070014850 Process for the preparation of dispersible tablets of cephalexin |
| 01/18/2007 | US20070014849 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 01/18/2007 | US20070014848 Resorbable Polyetheresters and Medicinal Implants Made Therefrom |
| 01/18/2007 | US20070014847 Coated capsules and methods of making and using the same |
| 01/18/2007 | US20070014846 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 01/18/2007 | US20070014845 Liposomal delivery vehicle for hydrophobic drugs |
| 01/18/2007 | US20070014844 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine |
| 01/18/2007 | US20070014843 Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
| 01/18/2007 | US20070014842 Pharmaceutical liposomal compositions |
| 01/18/2007 | US20070014841 Pharmaceutical compositions |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014839 Decomposer film for transdermal patches |
| 01/18/2007 | US20070014838 hydrolase enzyme immobilized within polyelectrolyte (polyethyleneimine, polyacrylic acid , polystyrene sulfonate, polydiallyldimethylammonium chloride), depositing endcapping agent ( 1,2-dihydroxypropyl methacrylate, 1,2-dihydroxypropyl 4-vinylbenzyl ether), polymerizing end capper; chemical resistance |